The Texas legislature has passed a bill that would create a state-backed research consortium to conduct clinical trials on ibogaine as a possible treatment for substance use disorders and other mental health conditions, with the goal of developing a drug that would win U.S. Food and Drug Administration (FDA) approval.

The state would retain a commercial interest in “all intellectual property that may be generated over the course of the drug development clinical ...